Author: Eunoia Consulting Co. | Published: June 17, 2026
AI fluency is not the same as AI expertise. You do not need to train a model or write code. What healthcare practice leaders need in 2026 is a working vocabulary, a set of evaluation frameworks, and the confidence to ask the right questions of vendors and staff deploying AI systems that affect patients and practice operations. This article defines what AI fluency means, why it matters now, and how to build it systematically.
A physician who cannot read a lab report is not a physician who can lead a clinical team. In 2026, a healthcare practice leader who cannot evaluate an AI claim, interrogate a vendor's model performance, or articulate an AI governance position is increasingly in the same position — technically functional, but strategically blind in the domain that is reshaping their industry.
AI fluency is not the same as AI expertise. You do not need to train a model or write code. What you need is a working vocabulary, a set of evaluation frameworks, and the confidence to ask the right questions of the people and vendors who are building AI systems that will affect your patients and your practice.
AI fluency for healthcare leaders is the ability to understand what an AI system does and does not do at a conceptual level sufficient to evaluate its clinical and operational implications. It means being able to ask meaningful questions about model performance, training data, bias, and failure modes. It means identifying when an AI vendor's claims are credible versus when they are marketing language. It means participating in governance conversations about AI deployment, oversight, and accountability, and communicating AI decisions and limitations to staff, patients, and boards.
AI fluency does not require you to understand gradient descent, write Python, or interpret a confusion matrix in detail. It does require you to know what a confusion matrix is, why it matters for a diagnostic AI tool, and what questions to ask when a vendor presents one.
Three converging forces are making AI fluency a leadership requirement in 2026 rather than a nice-to-have.
Regulatory accountability is shifting to deployers. The EU AI Act, evolving FDA guidance on AI-enabled medical devices, and state-level AI legislation are all moving toward holding deploying organisations — not just AI vendors — accountable for AI system performance and governance. Practice leaders who cannot demonstrate informed oversight of AI systems in their organisation are increasingly exposed.
AI is embedded in systems you already use. The EHR you are running today almost certainly has AI features — clinical decision support, coding suggestions, prior authorisation automation. The question is no longer whether AI is in your practice; it is whether you know where it is and whether it is being used appropriately.
Staff are adopting AI independently. Physicians, nurses, and administrative staff are using consumer AI tools — ChatGPT, Claude, Gemini — for clinical documentation, patient communication drafts, and research. Without leadership that can set informed policy, this shadow AI adoption creates compliance and quality risks that are invisible until they become incidents.
Building AI fluency is a structured process, not a single training event. The core competencies fall into four areas.
Conceptual understanding means being able to explain the difference between a rule-based clinical decision support tool and a machine learning model, understanding why training data composition affects model performance, and knowing what "hallucination" means in the context of large language models used for clinical documentation.
Evaluation skills mean that when a vendor presents an AI tool, you can ask: What was the training dataset, and does it represent my patient population? What is the false negative rate for this diagnostic tool, and what are the clinical consequences of a missed case? Has this tool been validated in a setting comparable to mine?
Governance awareness means understanding what a responsible AI use policy looks like, why human oversight requirements exist, and how to structure accountability for AI-related decisions in your organisation.
Communication capability means being able to explain AI limitations to clinical staff in plain language, communicate your organisation's AI governance position to patients who ask, and brief your board on AI risk without requiring a technical translator.
AI fluency is built through deliberate exposure, not passive consumption. Start with your own systems — request a meeting with your EHR vendor specifically to understand what AI features are active in your current subscription, how they work, and what oversight mechanisms exist. This single conversation will surface more relevant AI fluency questions than any general course.
Read one AI governance framework. The NIST AI Risk Management Framework and the EU AI Act's high-risk AI obligations are both publicly available and written for non-technical audiences. Reading one of them cover-to-cover takes less than two hours and provides a vocabulary for every AI governance conversation you will have.
In organisations too small to justify a full-time Chief AI Officer, designating an existing leader — a CMO, COO, or practice manager — as the accountable owner for AI governance decisions is a meaningful step. That person's fluency development becomes a business priority, not a personal interest.
The practices that build AI-fluent leadership teams now will be better positioned to adopt AI responsibly, avoid costly governance failures, and compete effectively as AI becomes a standard component of healthcare delivery.
Eunoia Consulting Co. helps healthcare practice leaders build AI governance capability and operational AI strategy. Contact us to discuss your organisation's AI readiness.